Boston, MA, United States of America

Willmen Youngsaye

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 9.3

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Cambridge, MA (US) (2021)
  • Boston, MA (US) (2017 - 2024)

Company Filing History:


Years Active: 2017-2024

where 'Filed Patents' based on already Granted Patents

4 patents (USPTO):

Title: The Innovative Contributions of Willmen Youngsaye

Introduction

Willmen Youngsaye is a notable inventor based in Boston, MA, with a remarkable portfolio that includes four patents. His work primarily focuses on compounds that modulate kinase activity, which has significant implications in the medical field, especially concerning cancer treatment.

Latest Patents

Youngsaye's latest innovations include groundbreaking patents such as "Heteroaryl compounds for kinase inhibition." This invention details compounds and pharmaceutical compositions that specifically target and modulate kinase activities, including those associated with mutant EGFR and HER2. Another significant patent is for "Anilinopyrimidines as haematopoietic progenitor kinase 1 (HPK1) inhibitors," which focuses on HPK1 inhibitors effective in treating cancers and diseases mediated by serine-threonine kinases.

Career Highlights

Throughout his career, Willmen Youngsaye has significantly contributed to the pharmaceutical industry, particularly during his tenure at respected organizations like Ariad Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited. His expertise in kinase inhibition has positioned him as a critical player in developing novel therapeutic strategies.

Collaborations

Youngsaye has collaborated with several esteemed professionals, including Wei-Sheng Huang and Xiaotian Zhu. These partnerships have further amplified his impact on the field of cancer research and kinase activity modulation.

Conclusion

Willmen Youngsaye's innovative spirit and dedication to research underscore his vital role in advancing pharmaceutical science. His patents not only highlight his ingenuity but also offer promising avenues for improving treatments for cancer and other kinase-related conditions. His work continues to inspire and pave the way for future innovations in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…